These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30981648)

  • 1. Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course.
    Castro K; Ntranos A; Amatruda M; Petracca M; Kosa P; Chen EY; Morstein J; Trauner D; Watson CT; Kiebish MA; Bielekova B; Inglese M; Katz Sand I; Casaccia P
    EBioMedicine; 2019 May; 43():392-410. PubMed ID: 30981648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression.
    Ewing E; Kular L; Fernandes SJ; Karathanasis N; Lagani V; Ruhrmann S; Tsamardinos I; Tegner J; Piehl F; Gomez-Cabrero D; Jagodic M
    EBioMedicine; 2019 May; 43():411-423. PubMed ID: 31053557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
    Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
    Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation microarrays identify epigenetically regulated lipid related genes in obese patients with hypercholesterolemia.
    Płatek T; Polus A; Góralska J; Raźny U; Gruca A; Kieć-Wilk B; Zabielski P; Kapusta M; Słowińska-Solnica K; Solnica B; Malczewska-Malec M; Dembińska-Kieć A
    Mol Med; 2020 Oct; 26(1):93. PubMed ID: 33028190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients.
    Kiselev I; Danilova L; Baulina N; Baturina O; Kabilov M; Boyko A; Kulakova O; Favorova O
    Mult Scler Relat Disord; 2022 Apr; 60():103714. PubMed ID: 35245816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
    van Doorn R; Nijland PG; Dekker N; Witte ME; Lopes-Pinheiro MA; van het Hof B; Kooij G; Reijerkerk A; Dijkstra C; van van der Valk P; van Horssen J; de Vries HE
    Acta Neuropathol; 2012 Sep; 124(3):397-410. PubMed ID: 22810490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between obesity and oligoclonal band formation in multiple sclerosis patients.
    Çoban A; Çevik D; Özyurt S; Gencer M; Tüzün E; Türkoğlu R
    Obes Res Clin Pract; 2015; 9(5):533-5. PubMed ID: 26193825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.
    Severa M; Rizzo F; Srinivasan S; Di Dario M; Giacomini E; Buscarinu MC; Cruciani M; Etna MP; Sandini S; Mechelli R; Farina A; Trivedi P; Hertzog PJ; Salvetti M; Farina C; Coccia EM
    J Autoimmun; 2019 Jul; 101():1-16. PubMed ID: 31047767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.
    Carlström KE; Ewing E; Granqvist M; Gyllenberg A; Aeinehband S; Enoksson SL; Checa A; Badam TVS; Huang J; Gomez-Cabrero D; Gustafsson M; Al Nimer F; Wheelock CE; Kockum I; Olsson T; Jagodic M; Piehl F
    Nat Commun; 2019 Jul; 10(1):3081. PubMed ID: 31300673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis.
    Zhang Y; Zhou Y; van der Mei IAF; Simpson S; Ponsonby AL; Lucas RM; Tettey P; Charlesworth J; Kostner K; Taylor BV;
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):636-641. PubMed ID: 30782980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.
    Haschka D; Tymoszuk P; Bsteh G; Petzer V; Berek K; Theurl I; Berger T; Weiss G
    Front Immunol; 2020; 11():594. PubMed ID: 32411125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of ceramides and their synthesizing enzymes for multiple sclerosis.
    Kurz J; Brunkhorst R; Foerch C; Blum L; Henke M; Gabriel L; Ulshöfer T; Ferreirós N; Parnham MJ; Geisslinger G; Schiffmann S
    Clin Sci (Lond); 2018 Sep; 132(17):1963-1976. PubMed ID: 30219773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index, but not vitamin D status, is associated with brain volume change in MS.
    Mowry EM; Azevedo CJ; McCulloch CE; Okuda DT; Lincoln RR; Waubant E; Hauser SL; Pelletier D
    Neurology; 2018 Dec; 91(24):e2256-e2264. PubMed ID: 30429274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular disease risk factors in multiple sclerosis: Effect on metabolism and brain volumes.
    Sammi MK; Fryman A; Baker E; Moloney B; Powers K; West R; Bittner F; Lane M; Martin K; Pepelyayeva Y; Anderson VC; Rooney WD; Yadav V
    Mult Scler Relat Disord; 2023 Jun; 74():104675. PubMed ID: 37121104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy.
    Slezáková D; Kadlic P; Jezberová M; Boleková V; Valkovič P; Minar M
    Neurol Neurochir Pol; 2023; 57(3):282-288. PubMed ID: 37144903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism.
    Fitzgerald KC; Smith MD; Kim S; Sotirchos ES; Kornberg MD; Douglas M; Nourbakhsh B; Graves J; Rattan R; Poisson L; Cerghet M; Mowry EM; Waubant E; Giri S; Calabresi PA; Bhargava P
    Cell Rep Med; 2021 Oct; 2(10):100424. PubMed ID: 34755135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.
    Graetz C; Gröger A; Luessi F; Salmen A; Zöller D; Schultz J; Siller N; Fleischer V; Bellenberg B; Berthele A; Biberacher V; Havla J; Hecker M; Hohlfeld R; Infante-Duarte C; Kirschke JS; Kümpfel T; Linker R; Paul F; Pfeuffer S; Sämann P; Toenges G; Weber F; Zettl UK; Jahn-Eimermacher A; Antony G; Groppa S; Wiendl H; Hemmer B; Mühlau M; Lukas C; Gold R; Lill CM; Zipp F
    Mult Scler; 2019 Apr; 25(5):661-668. PubMed ID: 29532745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INFβ treatment affects global DNA methylation in monocytes of patients with multiple sclerosis.
    Diniz SN; da Silva CF; de Almeida IT; da Silva Costa FE; de Oliveira EML
    J Neuroimmunol; 2021 Jun; 355():577563. PubMed ID: 33853016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-Methylation and Body Composition in Preschool Children: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study.
    Rzehak P; Covic M; Saffery R; Reischl E; Wahl S; Grote V; Weber M; Xhonneux A; Langhendries JP; Ferre N; Closa-Monasterolo R; Escribano J; Verduci E; Riva E; Socha P; Gruszfeld D; Koletzko B
    Sci Rep; 2017 Oct; 7(1):14349. PubMed ID: 29084944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.